Form 4 filings across 3 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$1.9M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
1 of 7 filings we hold was filed after the two-business-day deadline. The furthest past the deadline was 1 business day late.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured
The 28 most recent Form 4 transactions.
| Sep 1 | CRNX | Crinetics Pharmaceuticals,… | DTOISS◆ | 12,500 | $40.29 | $503.6K | — | Open the original filing on SEC.gov |
| Sep 1 | CRNX | Crinetics Pharmaceuticals,… | DTOISS◆ | 17,500 | $64.68 | $1.1M | — | Open the original filing on SEC.gov |
| Sep 1 | CRNX | Crinetics Pharmaceuticals,… | DTOISS◆ | 17,500 | $66.71 | $1.2M | — | Open the original filing on SEC.gov |
| Sep 1 | CRNX | Crinetics Pharmaceuticals,… | DTOISS◆ | 17,500 | $64.77 | $1.1M | — | Open the original filing on SEC.gov |
| Sep 1 | CRNX | Crinetics Pharmaceuticals,… | DTOISS◆ | 12,500 | $61.77 | $772.1K | — | Open the original filing on SEC.gov |
| Sep 1 | CRNX | Crinetics Pharmaceuticals,… | DTOISS◆ | 12,500 | $61.76 | $772K | — | Open the original filing on SEC.gov |
| Sep 1 | CRNX | Crinetics Pharmaceuticals,… | DTOISS | 5,925 | $85.00 | $503.6K | -100.0% | Open the original filing on SEC.gov |
| Sep 1 | CRNX | Crinetics Pharmaceuticals,… | DTOISS | 116,146 | $85.00 | $9.9M | -95.2% | Open the original filing on SEC.gov |
| Jul 15 | CYTK | Cytokinetics INC | AGRANT | 75 | $82.62 | $6.2K | +0.2% | Open the original filing on SEC.gov |
| Jun 18 | CRNX | Crinetics Pharmaceuticals,… | AGRANT◆ | 9,730 | — | — | — | Open the original filing on SEC.gov |
| Jun 18 | CRNX | Crinetics Pharmaceuticals,… | AGRANT | 5,925 | — | — | +5.1% | Open the original filing on SEC.gov |
| May 27 | CYTK | Cytokinetics INC | AGRANT◆ | 4,301 | — | — | — | Open the original filing on SEC.gov |
| May 27 | CYTK | Cytokinetics INC | AGRANT | 2,851 | — | — | +8.7% | Open the original filing on SEC.gov |
| May 5 | CYTK | Cytokinetics INC | MEXER◷◆ | 4,032 | — | — | — | Open the original filing on SEC.gov |
| May 5 | CYTK | Cytokinetics INC | SSELL◷ | 4,032 | $75.00 | $302.4K | -11.0% | Open the original filing on SEC.gov |
| May 5 | CYTK | Cytokinetics INC | MEXER◷ | 4,032 | $12.40 | $50K | +12.3% | Open the original filing on SEC.gov |
| Apr 15 | CYTK | Cytokinetics INC | AGRANT | 95 | $65.37 | $6.2K | +0.3% | Open the original filing on SEC.gov |
| Jan 15 | CYTK | Cytokinetics INC | AGRANT | 98 | $63.44 | $6.2K | +0.3% | Open the original filing on SEC.gov |
| Jan 2 | DRMA | Dermata Therapeutics, Inc. | AGRANT◆ | 2,500 | — | — | — | Open the original filing on SEC.gov |
| Dec 22, 2025 | CYTK | Cytokinetics INC | MEXER◷◆ | 20,000 | — | — | — | Open the original filing on SEC.gov |
| Dec 22, 2025 | CYTK | Cytokinetics INC | SSELL◷ | 20,000 | $66.14 | $1.3M | -38.1% | Open the original filing on SEC.gov |
| Dec 22, 2025 | CYTK | Cytokinetics INC | MEXER◷ | 20,000 | $7.61 | $152.2K | +61.6% | Open the original filing on SEC.gov |
| Oct 27, 2025 | CYTK | Cytokinetics INC | MEXER◷◆ | 4,375 | — | — | — | Open the original filing on SEC.gov |
| Oct 27, 2025 | CYTK | Cytokinetics INC | SSELL◷ | 4,375 | $58.68 | $256.7K | -11.9% | Open the original filing on SEC.gov |
| Oct 27, 2025 | CYTK | Cytokinetics INC | MEXER◷ | 4,375 | $10.00 | $43.8K | +13.5% | Open the original filing on SEC.gov |
| Oct 15, 2025 | CYTK | Cytokinetics INC | AGRANT | 99 | $62.80 | $6.2K | +0.3% | Open the original filing on SEC.gov |